KMO and carcinoma: Decreasedformation of these Kyn metabolites by KMO inhibition can also preventtumoral immune escape and it is noteworthy that KMO is upregulated inhepatocellular carcinoma [192] andtriple negative breast cancer [193].The potential impact of KMO inhibition on XA formation remains to beexplored.